durapatite has been researched along with ciprofloxacin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Amaro Martins, VC; Goissis, G | 1 |
| Dash, AK; Génin, F; Luo, P; Pham, HH | 1 |
| Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I | 1 |
| Blanchemain, N; Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Neut, C | 1 |
| Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Leprêtre, S; Martel, B; Neut, C; Vermet, G | 1 |
| Blanchemain, N; Chai, F; Flament, MP; Hildebrand, HF; Hoang Thi, TH; Leprêtre, S; Martel, B; Siepmann, F; Siepmann, J | 1 |
| Laha, B; Nayak, AK; Sen, KK | 1 |
| Devaraj, SN; Girija, EK; Kalkura, SN; Raja, SB; Savithri, K; Sridevi, TS; Thamizhavel, A; Vani, R | 1 |
| Kumar, J; Ramakrishnan, V; Ramasamy, S; Venkatasubbu, GD | 1 |
| Andrade, GF; da Silva Júnior, AC; de Sousa, EM; Goes, AM; Gomide, VS | 1 |
| Biswas, R; Jayaram, L; Krishnan, AG; Nair, M | 1 |
| Bouyarmane, H; Coradin, T; El Hanbali, I; El Karbane, M; Laghzizil, A; Masse, S; Rami, A; Saoiabi, A; Saoiabi, S | 1 |
| Meenakshi Sundaram, N; Nithya, R | 1 |
| Chen, Y; Duan, L; Lan, T; Wang, F; Wei, W; Zhang, S; Zhao, B | 1 |
| Balasoiu, M; Ciocilteu, MV; Croitoru, O; Ducu, C; Manda, VC; Melinte, R; Mocanu, A; Mocanu, AG; Neamtu, J; Nicolaescu, OE; Nicolicescu, C; Turcu-Stiolica, A | 1 |
| Baldini, M; Benedini, LA; Laiuppa, JA; Messina, PV; Placente, D; Santillán, GE | 1 |
| Balloni, S; Bodo, M; Chieruzzi, M; Cianetti, S; Lombardo, G; Marinucci, L; Pagano, S; Torre, L | 1 |
| Karimi, MH; Mahdavinia, GR; Massoumi, B; Soltaniniya, M | 1 |
| Benedini, L; Messina, P; Placente, D; Ruso, J | 1 |
| Baldini, M; Benedini, L; Laiuppa, J; Messina, P; Santillán, G | 1 |
| Ahmadian, Z; Chu, PK; Mehrjou, B; Shanaghi, A; Souri, AR | 1 |
| Ait Said, H; Barroug, A; Ben Youcef, H; Hakkou, R; Lahcini, M; Lefeuvre, B; Noukrati, H; Oudadesse, H | 1 |
| Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
| Bilewicz, R; Bobrowska, K; Golec, P; Prześniak-Welenc, M; Sadowska, K; Stolarczyk, K | 1 |
24 other study(ies) available for durapatite and ciprofloxacin
| Article | Year |
|---|---|
Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Biocompatible Materials; Biodegradation, Environmental; Bone Diseases; Calcium; Chelating Agents; Ciprofloxacin; Collagen; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Delivery Systems; Durapatite; Gentamicins; Gram-Negative Bacteria; Male; Norfloxacin; Osteogenesis; Rats | 2000 |
Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique.
Topics: Bone Diseases, Infectious; Chemical Precipitation; Chemistry, Pharmaceutical; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Durapatite; Microspheres | 2002 |
Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Blood Platelets; Body Weight; Calcium Phosphates; Ciprofloxacin; Disease Models, Animal; Durapatite; Femur; Gamma Rays; Humans; Implants, Experimental; Leukocytes; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biocompatible Materials; Ciprofloxacin; Durapatite; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Particle Size; Pilot Projects; Porosity; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Vancomycin | 2007 |
Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Bone Transplantation; Ciprofloxacin; Cyclodextrins; Drug Delivery Systems; Durapatite; Humans; Kinetics; Mice; Polymers; Staphylococcus aureus; Vancomycin | 2009 |
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Bone Substitutes; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Delivery Systems; Drug Stability; Durapatite; Gels; Kinetics; Sepharose; Vancomycin | 2010 |
Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".
Topics: Anti-Bacterial Agents; Biocompatible Materials; Chemical Precipitation; Ciprofloxacin; Delayed-Action Preparations; Drug Implants; Durapatite; Excipients; Galactans; Humans; Mannans; Models, Theoretical; Osteomyelitis; Phosphoric Acids; Plant Gums; Time Factors | 2011 |
Surfactant free rapid synthesis of hydroxyapatite nanorods by a microwave irradiation method for the treatment of bone infection.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Bone Diseases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; Durapatite; Escherichia coli; Humans; Microbial Sensitivity Tests; Microwaves; Nanotechnology; Nanotubes; Rifampin; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Surface-Active Agents; X-Ray Diffraction | 2011 |
Hydroxyapatite-alginate nanocomposite as drug delivery matrix for sustained release of ciprofloxacin.
Topics: Alginates; Anti-Infective Agents; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Durapatite; Glucuronic Acid; Hexuronic Acids; Nanocomposites | 2011 |
An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies.
Topics: Absorption, Physicochemical; Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Ciprofloxacin; Delayed-Action Preparations; Diffusion; Drug Stability; Durapatite; Humans; Mesenchymal Stem Cells; Porosity; Silicon Dioxide | 2014 |
Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacterial Adhesion; Cells, Cultured; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Durapatite; Gelatin; Humans; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Osteomyelitis; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds; X-Ray Diffraction | 2015 |
Parameters influencing ciprofloxacin, ofloxacin, amoxicillin and sulfamethoxazole retention by natural and converted calcium phosphates.
Topics: Adsorption; Amoxicillin; Anti-Bacterial Agents; Calcium Phosphates; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Durapatite; Hydrogen-Ion Concentration; Kinetics; Ofloxacin; Powders; Sulfamethoxazole | 2015 |
Biodegradation and cytotoxicity of ciprofloxacin-loaded hydroxyapatite-polycaprolactone nanocomposite film for sustainable bone implants.
Topics: Animals; Bone and Bones; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Drug Delivery Systems; Durapatite; Humans; Mice; Nanocomposites; NIH 3T3 Cells; Osteoblasts; Polyesters; Polymers; Prostheses and Implants; Topoisomerase II Inhibitors | 2015 |
Adsorptive Removal and Adsorption Kinetics of Fluoroquinolone by Nano-Hydroxyapatite.
Topics: Adsorption; Ciprofloxacin; Durapatite; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Kinetics; Temperature; Water Pollutants, Chemical | 2015 |
Hydroxyapatite-ciprofloxacin delivery system: Synthesis, characterisation and antibacterial activity.
Topics: Anti-Bacterial Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Durapatite; Dynamic Light Scattering; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; X-Ray Diffraction | 2018 |
Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cell Survival; Cells, Cultured; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Durapatite; Escherichia coli; Ibuprofen; Lipids; Membranes, Artificial; Nanoparticles; Osteoblasts; Particle Size; Pseudomonas aeruginosa; Rats, Wistar; Staphylococcus aureus | 2018 |
Biological, thermal and mechanical characterization of modified glass ionomer cements: The role of nanohydroxyapatite, ciprofloxacin and zinc l-carnosine.
Topics: Calorimetry, Differential Scanning; Carnosine; Cell Death; Cell Line; Cell Survival; Ciprofloxacin; Compressive Strength; Durapatite; Fibroblasts; Glass Ionomer Cements; Humans; Keratinocytes; Materials Testing; Microbial Sensitivity Tests; Nanoparticles; Organometallic Compounds; Streptococcus mutans; Stress, Mechanical; Temperature; Zinc Compounds | 2019 |
In vitro evaluation of sustained ciprofloxacin release from κ-carrageenan-crosslinked chitosan/hydroxyapatite hydrogel nanocomposites.
Topics: Anti-Bacterial Agents; Carrageenan; Chitosan; Ciprofloxacin; Cross-Linking Reagents; Drug Liberation; Durapatite; Escherichia coli; Hydrogels; Kinetics; Microbial Sensitivity Tests; Nanocomposites; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; X-Ray Diffraction | 2019 |
Adsorption/desorption study of antibiotic and anti-inflammatory drugs onto bioactive hydroxyapatite nano-rods.
Topics: Adsorption; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Durapatite; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Nanotubes; Osmolar Concentration; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2019 |
Antibacterial alginate/nano-hydroxyapatite composites for bone tissue engineering: Assessment of their bioactivity, biocompatibility, and antibacterial activity.
Topics: Alginates; Animals; Anti-Bacterial Agents; Bacteria; Bone Substitutes; Cell Line; Cell Survival; Ciprofloxacin; Drug Liberation; Durapatite; Microscopy, Electron, Transmission; Nanoparticles; Osteoblasts; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2020 |
Enhanced corrosion resistance, antibacterial properties, and biocompatibility by hierarchical hydroxyapatite/ciprofloxacin-calcium phosphate coating on nitrided NiTi alloy.
Topics: Alloys; Anti-Bacterial Agents; Ciprofloxacin; Coated Materials, Biocompatible; Corrosion; Durapatite; Escherichia coli; Surface Properties | 2021 |
Formulation and characterization of hydroxyapatite-based composite with enhanced compressive strength and controlled antibiotic release.
Topics: Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Compressive Strength; Delayed-Action Preparations; Durapatite; Escherichia coli; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Thermogravimetry; X-Ray Diffraction | 2021 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Bovine Serum Albumin - Hydroxyapatite Nanoflowers as Potential Local Drug Delivery System of Ciprofloxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Durapatite; Serum Albumin, Bovine; Staphylococcus aureus | 2023 |